96 papers
Cardiovascular medicine focuses on the heart and blood vessels, exploring how to prevent, diagnose, and treat conditions that affect our circulation. This vital field ranges from understanding high blood pressure and heart failure to investigating the latest breakthroughs in surgical techniques and lifestyle interventions. Because these discoveries directly impact public health, staying informed about emerging research is more important than ever for both specialists and curious readers.
At Gist.Science, we process every new preprint in this category as it appears on medRxiv, ensuring you have immediate access to the latest findings before they undergo formal peer review. For each study, we provide both a plain-language explanation to clarify the core concepts and a detailed technical summary for those seeking deeper scientific context. Below are the latest papers in cardiovascular medicine, organized to help you navigate the most recent developments shaping the future of heart health.
This study demonstrates that genetic testing for HFE variants in patients with early-onset atrial fibrillation can identify individuals with hereditary hemochromatosis and iron overload, enabling early intervention through therapeutic phlebotomy despite the absence of cardiac siderosis.
This study identifies specific circulating and cardiac N-glycan signatures, particularly the glycan A2G2S2, as novel biomarkers that reflect inflammation-driven atrial remodeling and accurately classify atrial fibrillation.
This study demonstrates that the left atrial to left ventricular (LA:LV) volume ratio is a superior marker for atrial cardiopathy compared to indexed left atrial volume (LAVi), showing stronger associations with ischemic stroke risk, cognitive dysfunction, and the identification of atrial fibrillation as a stroke etiology.
Leveraging the Million Veteran Program, this study identified causal DNA methylation markers for abdominal aortic aneurysm, elucidated their regulation through inflammatory and cardiometabolic pathways, and demonstrated that a methylation-based risk score significantly improves prediction accuracy beyond clinical models.
This study of nearly half a million UK Biobank participants reveals that chronic systemic inflammation, driven by gene-environment interactions and mediated by cytokines like IL-1 receptor antagonist, leads to restrictive cardiac remodeling and significantly increases the risk of major adverse cardiovascular events.